Disruption of gene expression and induction of apoptosis in prostate cancer cells by a DNA-damaging agent tethered to an androgen receptor ligand

被引:28
作者
Marquis, JC
Hillier, SM
Dinaut, AN
Rodrigues, D
Mitra, K
Essigmann, JM
Croy, RG
机构
[1] MIT, Dept Chem, Cambridge, MA 02139 USA
[2] MIT, Biol Engn Div, Cambridge, MA 02139 USA
来源
CHEMISTRY & BIOLOGY | 2005年 / 12卷 / 07期
关键词
D O I
10.1016/j.chembiol.2005.05.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The goal of our work was the design of DNA-damaging agents that disrupt both DNA repair and signaling pathways in prostate tumor cells. A DNA alkylator (N,N-bis-2-chloroethyl aniline) was linked to a steroid ligand (17 beta-hyroxy-estra-Delta(4(5),9(10))-3-one) to produce a complex molecule (11 beta-dichloro) that forms DNA adducts that bind the androgen receptor (AR). We speculated that DNA adducts in an AR-DNA adduct complex would be camouflaged from DNA repair proteins that would otherwise remove the adducts in prostate cancer cells. Furthermore, transcription dependent on the AR would be antagonized by AR redistribution to sites distant from AR-driven promoters. The anticancer potential of 11 beta-dichloro was demonstrated against prostate cancer cells in vitro and in vivo. 11 beta-dichloro induces a unique pattern of gene disruption, induces apoptosis in apoptosis-resistant cells, and shows promising anticancer activity in animals.
引用
收藏
页码:779 / 787
页数:9
相关论文
共 43 条
[1]   Control of the SCFSkp2-Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase [J].
Bashir, T ;
Dorrello, NV ;
Amador, V ;
Guardavaccaro, D ;
Pagano, M .
NATURE, 2004, 428 (6979) :190-193
[2]   Antiandrogens: selective androgen receptor modulators [J].
Berrevoets, CA ;
Umar, A ;
Brinkmann, AO .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 198 (1-2) :97-103
[3]   ANDROGEN-LINKED ALKYLATING-AGENTS - BIOLOGICAL-ACTIVITY IN METHYLNITROSOUREA-INDUCED RAT MAMMARY-CARCINOMA [J].
BRIX, HP ;
BERGER, MR ;
SCHNEIDER, MR ;
TANG, WC ;
EISENBRAND, G .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (06) :538-549
[4]   Contribution of the androgen receptor to prostate cancer predisposition and progression [J].
Buchanan, G ;
Irvine, RA ;
Coetzee, GA ;
Tilley, WD .
CANCER AND METASTASIS REVIEWS, 2001, 20 (3-4) :207-223
[5]   SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 [J].
Carrano, AC ;
Eytan, E ;
Hershko, A ;
Pagano, M .
NATURE CELL BIOLOGY, 1999, 1 (04) :193-199
[6]   Plasma membrane phospholipid asymmetry precedes DNA fragmentation in different apoptotic cell models [J].
Chan, A ;
Reiter, R ;
Wiese, S ;
Fertig, G ;
Gold, R .
HISTOCHEMISTRY AND CELL BIOLOGY, 1998, 110 (06) :553-558
[7]  
Devita Vincent T. Jr., 1997, P333
[8]  
DEWINTER JAR, 1994, AM J PATHOL, V144, P735
[9]   NITROSOUREAS - MODES OF ACTION AND PERSPECTIVES IN THE USE OF HORMONE RECEPTOR AFFINE CARRIER MOLECULES [J].
EISENBRAND, G ;
BERGER, MR ;
BRIX, HP ;
FISCHER, JE ;
MUHLBAUER, K ;
NOWROUSIAN, MR ;
PRZYBILSKI, M ;
SCHNEIDER, MR ;
STAHL, W ;
TANG, W ;
ZELEZNY, O ;
ZELLER, WJ .
ACTA ONCOLOGICA, 1989, 28 (02) :203-211
[10]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825